The use of mycophenolate mofetil in treating patients with non responding aplastic anemia

Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug...

Descrizione completa

Dettagli Bibliografici
Autori principali: Gan, Gin Gin, Leong, C.F., Sangkar, J.V., Teh, A., Goh, K.Y., Cheong, S.K.
Natura: Articolo
Lingua:English
Pubblicazione: Malaysian Medical Association 2005
Soggetti:
Accesso online:http://eprints.um.edu.my/24590/1/Aplastic_Anemia.pdf

Documenti analoghi